RT Journal Article
SR Electronic
T1 Recurrent dissemination of SARS-CoV-2 through the Uruguayan-Brazilian border
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.06.20249026
DO 10.1101/2021.01.06.20249026
A1 Daiana Mir
A1 Natalia Rego
A1 Paola Cristina Resende
A1 Fernando López-Tort
A1 Tamara Fernandez-Calero
A1 Verónica Noya
A1 Mariana Brandes
A1 Tania Possi
A1 Mailen Arleo
A1 Natalia Reyes
A1 Matías Victoria
A1 Andrés Lizasoain
A1 Matías Castells
A1 Leticia Maya
A1 Matías Salvo
A1 Tatiana Schäffer Gregianini
A1 Marilda Tereza Mar da Rosa
A1 Letícia Garay Martins
A1 Cecilia Alonso
A1 Yasser Vega
A1 Cecilia Salazar
A1 Ignacio Ferrés
A1 Pablo Smircich
A1 Jose Sotelo
A1 Rafael Sebastián Fort
A1 Cecilia Mathó
A1 Ighor Arantes
A1 Luciana Appolinario
A1 Ana Carolina Mendonça
A1 María José Benitez-Galeano
A1 Martín Graña
A1 Camila Simoes
A1 Fernando Motta
A1 Marilda Mendonça Siqueira
A1 Gonzalo Bello
A1 Rodney Colina
A1 Lucía Spangenberg
YR 2021
UL http://medrxiv.org/content/early/2021/01/08/2021.01.06.20249026.abstract
AB Background Uruguay is one of the few countries in the Americas that successfully contained the COVID-19 epidemic during the first half of 2020. Nevertheless, the intensive human mobility across the dry border with Brazil is a major challenge for public health authorities. We aimed to investigate the origin of SARS-CoV-2 strains detected in Uruguayan localities bordering Brazil as well as to measure the viral flux across this ∼1,100 km uninterrupted dry frontier.Methods Using complete SARS-CoV-2 genomes from the Uruguayan-Brazilian bordering region and phylogeographic analyses, we inferred the virus dissemination frequency between Brazil and Uruguay and characterized local outbreak dynamics during the first months (May-July) of the pandemic.Findings Phylogenetic analyses revealed multiple introductions of SARS-CoV-2 Brazilian lineages B.1.1.28 and B.1.1.33 into Uruguayan localities at the bordering region. The most probable sources of viral strains introduced to Uruguay were the Southeast Brazilian region and the state of Rio Grande do Sul. Some of the viral strains introduced in Uruguayan border localities between early May and mid-July were able to locally spread and originated the first outbreaks detected outside the metropolitan region. The viral lineages responsible for Uruguayan suburban outbreaks were defined by a set of between four and 11 mutations (synonymous and non-synonymous) respect to the ancestral B.1.1.28 and B.1.1.33 viruses that arose in Brazil, supporting the notion of a rapid genetic differentiation between SARS-CoV-2 subpopulations spreading in South America.Interpretation Although Uruguayan borders have remained essentially closed to non-Uruguayan citizens, the inevitable flow of people across the dry border with Brazil allowed the repeated entry of the virus into Uruguay and the subsequent emergence of local outbreaks in Uruguayan border localities. Implementation of coordinated bi-national surveillance systems are crucial to achieve an efficient control of the SARS-CoV-2 spread across this kind of highly permeable borderland regions around the world.Evidence before this study Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causative agent of coronavirus disease 19 (COVID-19), was first detected in South America on February 26, 2020, it has rapidly spread through the region, causing nearly 350,000 deaths by December, 2020. In contrast to most American countries, Uruguay avoided an early exponential growth of SARS-CoV-2 cases and during the first six months of the pandemic it registered the lowest incidence of SARS-CoV-2 cases and deaths among South American countries. The intensive cross-border human mobility through the ∼1,100 km uninterrupted dry frontier between Uruguay and Brazil, might poses a major challenge for long-term control of the epidemic in Uruguay. Previous genomic studies conducted in Uruguay have analyzed sequences mostly sampled at the capital city, Montevideo, and detected prevalent SARS-CoV-2 lineages different from those described in Brazil, thus finding no evidence of frequent viral exchanges between these countries.Added value of this study Here we present the first genomic study of SARS-CoV-2 strains detected in different Uruguayan and Brazilian localities along the bordering region. The samples analyzed include 30% (n = 59) of all laboratory confirmed SARS-CoV-2 cases from Uruguayan departments at the Brazilian border between March and July, 2020, as well as 68 SARS-CoV-2 sequences from individuals diagnosed in the southernmost Brazilian state of Rio Grande do Sul between March and August, 2020. We demonstrate that SARS-CoV-2 viral lineages that widely spread in the Southeastern Brazilian region (B.1.1.28 and B.1.1.33) were also responsible for most viral infections in Rio Grande do Sul and neighboring Uruguayan localities. We further uncover that major outbreaks detected in Uruguayan localities bordering Brazil in May and June, 2020, were originated from two independent introduction events of the Brazilian SARS-CoV-2 lineage B.1.1.33, unlike previous outbreaks in the Uruguayan metropolitan region that were seeded by European SARS-CoV-2 lineages.Implications of all the available evidence Our findings confirm that although Uruguayan borders have remained essentially closed to non-Uruguayan citizens, dissemination of SARS-CoV-2 across the Uruguayan-Brazilian frontier was not fully suppressed and had the potential to ignite local transmission chains in Uruguay. These findings also highlight the relevance of implementing bi-national public health cooperation workforces combining epidemiologic and genomic data to monitor the viral spread throughout this kind of highly permeable dry frontiers around the world.Competing Interest StatementThe authors have declared no competing interest.Funding StatementBrazil: Funding support from CGLab/MoH (General Laboratories Coordination of Brazilian Ministry of Health), CVSLR/FIOCRUZ (Coordination of Health Surveillance and Reference Laboratories of Oswaldo Cruz Foundation), CNPq COVID-19 MCTI 402457/2020-0 and INOVA VPPCB-005-FIO437 20-2. Uruguay: This work was funded by the Manuel Perez Foundation that nucleated COVID19 donation fonds in the context of the project 'Vigilancia epidemiológica del COVID-19 en las fronteras uruguayas y análisis de su transmisión en el interior del país'Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved in Uruguay by the Ethics Committees of the Sanatorio Americano (CEI-SASA). Board members were: Dr. Oscar Cluzet, Dr. Enrique Mendez, Dr. Alberto Aliaga and Mr. Richard Riera. This study was approved in Brazil by following ethics committees: FIOCRUZ-IOC Ethics Committee: 68118417.6.0000.5248, and Brazilian Ministry of Health SISGEN: A1767C3.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData was uploaded to GISAID